Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Free Cash Flow: 2016-2024

Historic Free Cash Flow for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Dec 2024 value amounting to -$229.8 million.

  • Crinetics Pharmaceuticals' Free Cash Flow fell 76.13% to -$111.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$354.0 million, marking a year-over-year decrease of 72.19%. This contributed to the annual value of -$229.8 million for FY2024, which is 34.40% down from last year.
  • Crinetics Pharmaceuticals' Free Cash Flow amounted to -$229.8 million in FY2024, which was down 34.40% from -$171.0 million recorded in FY2023.
  • Crinetics Pharmaceuticals' 5-year Free Cash Flow high stood at -$62.2 million for FY2020, and its period low was -$229.8 million during FY2024.
  • Its 3-year average for Free Cash Flow is -$172.6 million, with a median of -$171.0 million in 2023.
  • Data for Crinetics Pharmaceuticals' Free Cash Flow shows a maximum YoY tumbled of 46.32% (in 2023) over the last 5 years.
  • Crinetics Pharmaceuticals' Free Cash Flow (Yearly) stood at -$62.2 million in 2020, then crashed by 43.10% to -$89.0 million in 2021, then crashed by 31.27% to -$116.9 million in 2022, then tumbled by 46.32% to -$171.0 million in 2023, then tumbled by 34.40% to -$229.8 million in 2024.